Exosens (EPA:EXENS)
France
· Delayed Price · Currency is EUR | Market Cap | 3.25B |
| Revenue (ttm) | 468.19M |
| Net Income (ttm) | 42.72M |
| Shares Out | 50.70M |
| EPS (ttm) | 0.84 |
| PE Ratio | 46.36 |
| Forward PE | 32.55 |
| Dividend | 0.30 (0.47%) |
| Ex-Dividend Date | May 27, 2026 |
| Volume | 69,898 |
| Average Volume | 125,775 |
| Open | 64.25 |
| Previous Close | 63.90 |
| Day's Range | 62.90 - 65.00 |
| 52-Week Range | 32.70 - 74.00 |
| Beta | n/a |
| RSI | 49.44 |
| Earnings Date | Jul 28, 2026 |
About Exosens
Exosens, together with its subsidiaries, develops, manufactures, and sells electro-optical technologies in France, Europe, North America, Asia, and internationally. It operates in two segments, Amplification and Detection and Imaging. The company offers image intensifier tubes; cameras, sensors, modules and cores, and imaging systems and solutions, including UV missile warning solution, atmospheric sounder, and spectroradiometer; and detection and imaging products for ions and electrons, photons, and neutrons, as well as micro pore optics and c... [Read more]
Financial Performance
In 2025, Exosens's revenue was 468.19 million, an increase of 22.10% compared to the previous year's 383.44 million. Earnings were 42.72 million, an increase of 67.31%.
Financial StatementsNews
Exosens FY25 Profit Climbs, Sees Growth Ahead; Stock Down
(RTTNews) - Exosens S.A (EXENS.PA, EXOSF), a French manufacturer of electro-optical technologies, reported Monday higher profit in fiscal 2025, benefited by growth in revenues.
Exosens Earnings Call Transcript: Q4 2025
Delivered record 2025 results with 22% revenue growth, 32.4% EBITDA margin, and strong cash flow. Upgraded 2026 guidance, continued capacity expansion, and strategic M&A support midterm ambition to reach EUR 1 billion revenue.
THEON completes the acquisition of a circa 9.8% stake in Exosens
PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS) 7 January 2026 – Theon International Plc (THEON) is pleased to announce the completion of the acquisition of a circa 9.8% stake in Exosens SA (E...
Theon International To Acquire 9.8% Stake In Exosens For EUR 268.7 Mln
(RTTNews) - Theon International Plc announced that it has signed a definitive agreement with HLD Europe SCA, Invest Prince Henri SCA, and Invest Gamma Sarl—investment entities affiliated with Groupe H...
Exosens Earnings Call Transcript: Q2 2025
H1 2025 saw 20% revenue growth and 24% adjusted EBITDA growth, driven by strong defense demand, acquisitions, and margin expansion. Capacity investments and a robust backlog support positive guidance for 2025, with continued focus on R&D and selective M&A.
Exosens Earnings Call Transcript: Q4 2024
Revenue grew 35% to EUR 394 million in 2024, with EBITDA margin at 30.1% and net profit up 66%. Strong defense demand, capacity expansion, and successful M&A drove results. 2025 guidance anticipates continued double-digit growth and further margin improvement.